Nutex Health Inc

Nutex Health Inc

NUTX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.19B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nutex Health IncNutex Health Inc7.3-38%1.50.8
$323.00

Target Price by Analysts

86% upsideNutex Health Target Price DetailsTarget Price
$305.81

Current Fair Value

76.1% upside

Undervalued by 76.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.19 Billion
Enterprise Value$1.31 Billion
Earnings per Share$11.13
Beta2
Outstanding Shares6,849,535

Return

Return on Equity37.82%ROE
Return on Assets15.95%
Return on Invested Capital28.91%

Valuation & Multiples

P/E Ratio7.29P/E Ratio
PEG-26.57PEG
Price to Sales1.5Price to Sales
Price to Book Ratio2.23Price to Book Ratio
Enterprise Value to Revenue1.64
Enterprise Value to EBIT5.02
Enterprise Value to Net Income7
Total Debt to Enterprise0.28
Debt to Equity0.84Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS
$5.71
Est. $5.54
Revenue
$217.61 M
Est. $214.82 M

Next Earnings Call

Expected Date
March 4, 2027
EPS Estimate
$5.87
Consensus analyst estimate
Revenue Estimate
$226.26 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %7.74%▼ 35.26%
Total Invested$112.51M▼ 77.70%
Investors Holding66▼ 90.00%

About Nutex Health Inc

14 employees

Nutex Health Insider Information FAQ

Stockcircle tracks 4 top investors with a current 13F position in Nutex Health. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider sale for Nutex Health in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.